January 2, 2018 5:45pm

A new month, year and day with many in lust for the upside but, love lasts longer than a session

 

What worked today, didn’t work last year …

 

Are we playing chutes and ladders - the exciting game of ups and downs?

 

Pre-open indications: 16 hits, 11 miss and 6 unrated

 

Out and about: Biostage (BSTG) jumps, when they had a plan, they couldn’t execute; now that they have nothing – day traders “play” as the old, dumped and forsaken shareholders prepare their next (legal) move!

Tuesday’s results have implications to Wednesday’s sector activity as a daily report may say little or a lot and it serves as insurance that all indications are being examined and evaluated!

 

Henry’omics:

From the pre-open’s newsletter, “…many sector equities are starting 2018 at bottoms. The danger of the year we are in: volatility, news flow and the overflow of trial issue, enrollments and setting the bar too low for a threshold to be met re real and illuminating clinical data.”

I also stated, “I will wait to see the momentum and volume from the first hours and day and the match the week!  The key will to NOT chase the tape this week, be cool and wait for the shot; you DO NOT want a “pink mist”.

The downtrodden and oversold raised their heads above the dust …

While volume was all over the map, luckily to the upside …

 

The advance/decline line scenario of 40 SCGT & RT covered companies:   

·         The open was positive with an A/DL of 24/11 and 5 flat ;

·         The mid-day was positive with an A/DL of 31/6 and 3 flats;

·         The close was positive with an A/DL of 31/7 and 2 flat;

 

MY working trend lines or indications:

… The greatest volume to the downside:  CYTX, BCLI, AXGN, CAPR and AST

… Upside volume was weighted to:  XON, VCEL, IMUC, ADVM and SGMO

… Biggest $ downside: AXGN (-$0.35), BCLI (-$0.27), AST (-$0.10), ISCO (-$0.05) and BLFS (-$0.04)

… Largest $ upside:  BLUE (+$3.80), XON (+$1.95), ONCE (+$1.89), JUNO (+$1.64) and RGNX (+$1.50)

… Flat: ATHX and MESO

 

 

Pre-open indications:

The oversold …

Bellicum Pharmaceuticals (BLCM) closed up +$0.82 – hit;

Fate Therapeutics (FATE) closed up +$0.19 – hit;

Histogenics (HSGX) closed up +$0.02 – hit;

Juno Therapeutics (JUNO) closed up +$1.64 – hit;

Verastem (VSTM) closed up +$0.14 – hit;

Mesoblast (MESO) closed up +$0.00 – hit;

MiMedx (MDXG) closed up +$0.37 – hit;

Sangamo (SGMO) closed up +$1.15 – hit;

 

The overbought:

Athersys (ATHX) closed up +$0.00 – hit;

Brainstorm Cell Therapy (BCLI) closed down -$0.27 – hit;

Cesca Therapeutic (KOOL) closed up +$0.10 – miss;

BioLife Solutions (BLFS) closed down -$0.04 – hit;

Capricor (CAPR) closed down - $0.01 – hit;

 

The “depreciators” – shareholders should avoid these after having been downtrodden:

Biostage (BSTG) closed up on WHAT (?) day-traders +$0.35 - miss

Cytori (CYTX) closed down -$0.01 – hit;

Fibrocell (FCSC) closed up +$0.04 – miss;

ImmunoCellular (IMUC) closed up +$0.0272 – miss;

Neuralstem (CUR) closed up +$0.31 – miss;

Osiris (OSIR) closed up +$0.15 (still with criminal proceedings over its head) – miss;

Northwest Bio (NWBO) closed up +$0.0098 – miss;

 

The movers and shakers – here is always something:

bluebird bio (BLUE) closed up +$3.80 – hit;

Regenxbio (RGNX) closed up +$1.50 – hit;

Spark Therapeutics (ONCE) closed up +$1.89 – hit;

 

Those who haven’t found there footing:

Caladrius Biosciences (CLBS) closed up +$0.19 – miss;

Pluristem (PSTI) closed up +$0.07 – miss;

VistaGen (VTGN) closed up +$0.05 – miss;

 

Stuck and unrated – who is watching this scattered flock has no sheep dogs:

Asterias Biotherapeutics (AST) closed down -$0.10;

BioTime (BTX) closed up +$0.18;

Applied Genetic Technologies (AGTC) closed up +$0.20;

Aduro BioTech (ADRO) closed up +$0.18;

Adverum (ADVM) closed up +$0.18;

Organovo Holdings (ONVO) closed up +$0.06;

 

Out and about:

The daily “BS” detector: Biostage (OTCQB: BSTGD) …

Opened at $0.87 (previous closed $0.87) then advanced +$0.35 or +40.23% to close up -$0.04 or +4.40% at $0.87 in a day’s range of $0.87 to $1.22 with 41,918 shares traded following the projected $1.32 post the 1-to-20 reverse split – a $4 M in-flow just followed a $30 M investment loss incurring a $47 M deficit!

Who and what’s “playing” the stock – day traders. NO scientist, partners other than those who want to be compensated. A CEO, CFO and 2 accountants don’t make a company who couldn’t pay their rent or communicate their issues to past “fleeced” shareholders …

... WHO are gathering … many calls!

It ain't over, more than many investors are agitating ... it will continue to spill over!!

Remember, day traders come and go as fast as a push on the SELL button with loyalty to NOTHING!

 

 

Daily analytics:

U.S. stocks kicked off 2018 on a positive note Tuesday, with major indexes rallying to record levels in a broad rally that saw five of the 11 primary sectors gaining more than 1% on the day. The NASDAQ had its biggest one-day percentage rise since Nov. 16.

·         The Dow rose 105 points, or 0.4%, to 24,824.

·         The S&P 500 rose 22 points, or 0.8%, to 2,696.

·         The NASDAQ gained 103.5 points, or 1.5%, to 7,007.

 

The CBOE Volatility Index (VIX) widely considered the best gauge of fear in the market, Tuesday traded at 9.77, down -11.50% …

  • Friday traded at 10.79, up +5.99% after Thursday traded at 10.28, down -2.77% after Wednesday traded at 10.47, up +2.15% after Tuesday traded at 10.25, up +0.47% following the previous Tuesday trading at 9.92, up +6.21% …

 

Welcome to another day of the sector’s roller coaster …

… The iShares Russell 2000 (IWM) indicated:

·         Tuesday was up +0.92%

·         Monday was New Year’s Day

·         Friday was down -0.80%

·         Thursday +0.40%

·         Wednesday -0.10%

·         Last Tuesday +0.04%

 

… The iShares NASDAQ Biotechnology (IBB) indicated:

·         Tuesday was up +2.41%

·         Monday was New Year’s Day

·         Friday was down -0.95%

·         Thursday was up +0.19%

·         Wednesday was up +0.14%

·         Last Tuesday closed up +0.47%

 

The count - decliners versus gainers:

……. look at the differences in decliners:

·         Tuesday’s decliners ranged from -0.63% <CAPR -$0.01> to -% <BCLI -$0.27> in 7 equities;

·         Monday was a holiday

·         Friday’s decliners ranged from -0.35% <FCSC -$0.00> to -6.52% <AST -$0.15> in 25 equities;

·         Thursday’s decliners ranged from -0.11% <BLUE -$0.20> to -8.28% <FATE -$0.55> in 20 equities;

·         Wednesday’s decliners ranged from -0.16% <BLFS -$0.01> to -6.21% <ONVO -$0.09> in 17 equities;

·         Last Tuesday’s decliners ranged from -0.47% <BLFS -$0.03> to -29.1% <BSTG -$0.375> in 16 equities;

Versus

… Look at the percentage’s (%) and spreads …

·         Tuesday’s gainers ranged from +0.32% <STML +$0.05> to +18.02% <CUR +$0.31> in 31 equities

·         Monday was a holiday

·         Friday’s gainers ranged from +0.17% <MESO +$0.01> to +29.37% <BCLI +$0.89> in 14 equities

·         Thursday’s gainers ranged from +0.53% <AXGN +$0.15> to +5.96% <ISCO +$0.09> in 15 equities

·         Wednesday’s gainers ranged from +0.43% <NWBO +$0.001> to +8.22% <CAPR +$0.12> in 20 equities

·         Last Tuesday’s gainers ranged from +0.30% <SGMO +$0.05> to +11.94% <FATE +$0.67> in 22 equities

 

Opinions expressed are those of the author and are subject to change, and not intended to be a forecast of future events, a guarantee of future results, nor investment advice.

Whether information or intelligence is good, bad or somewhere in between; I put into context what is relevant and useful for investors.  All investments are subject to risks. Investors should consider investment objectives.

Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.